Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kite Pharma Inc (KITE)

Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,314,552
  • Shares Outstanding, K 57,370
  • Annual Sales, $ 22,170 K
  • Annual Income, $ -267,070 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.68
  • Price/Sales 465.26
  • Price/Cash Flow N/A
  • Price/Book 14.33
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.87
  • Most Recent Earnings $-1.50 on 08/08/17
  • Next Earnings Date 11/08/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate -2.13
  • Number of Estimates 7
  • High Estimate -2.02
  • Low Estimate -2.26
  • Prior Year -1.49
  • Growth Rate Est. (year over year) -42.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
177.65 +1.32%
on 09/05/17
179.99 unch
on 10/03/17
+1.94 (+1.09%)
since 09/01/17
3-Month
100.09 +79.83%
on 07/10/17
179.99 unch
on 10/03/17
+75.56 (+72.35%)
since 07/03/17
52-Week
39.82 +352.01%
on 11/03/16
179.99 unch
on 10/03/17
+124.90 (+226.72%)
since 10/03/16

Business Summary

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of cancer immunotherapy products. The Company is developing a pipeline of eACT-based product candidates for the treatment of solid and hematological malignancies. Kite Pharma, Inc....

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 180.16
1st Resistance Point 179.98
Last Price 179.99
1st Support Level 179.58
2nd Support Level 179.36
3rd Support Level N/A

See More

52-Week High 179.99
Last Price 179.99
Fibonacci 61.8% 126.45
Fibonacci 50% 109.90
Fibonacci 38.2% 93.36
52-Week Low 39.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar